When: November 14-18, 2020
The AMIA 2020 Virtual Annual Symposium builds on more than 40 years of sharing pioneering research and insights for leveraging information to improve human health. Topics of interest span the spectrum from deciphering the underpinning phenomena of disease, to managing information and communications for improving patient care, to tracking the health of populations. The AMIA 2020 Annual Symposium showcases the latest innovations from the community of biomedical informatics researchers and practitioners.
The symposium brings together informatics professionals from diverse backgrounds committed to transforming health through informatics. From the leading experts in the field, to the students eager to get started, the AMIA 2020 Virtual Annual Symposium provides an opportunity to learn and to grow professionally, to network, and to flesh out ideas with colleagues and start new collaborations.
The symposium will be a full conference experience, and will feature the same high-quality, science-based learning opportunities AMIA conferences are known for. There will be plenty of opportunities for conversations and networking between attendees, presenters, exhibitors, sponsors, and informatics leaders.
AMIA recognizes and greatly appreciates the hard work and dedication many of its members put into developing the conference — especially their SPC and speakers. They have two engaging keynote presentations on tap for the Annual Symposium:
- Ruha Benjamin, PhD, will open the conference. She is a professor of African American studies at Princeton University and author of People’s Science: Bodies and Rights on the Stem Cell Frontier (Stanford University Press). She has studied the social dimensions of science, technology, and medicine for more than 15 years and speaks widely on issues of innovation, equity, health, and justice in the U.S. and globally.
- Their closing keynote speaker is AMIA member Josh Denny, MD, MS, FACMI. Josh is the Chief Executive Officer of the National Institutes of Health’s All of Us Research Program. He has been involved in All of Us from its inception, first as a member of the Advisory Committee to the (NIH) Director Precision Medicine Initiative Working Group, which developed the program’s initial scientific blueprint. He led the program’s initial prototyping project and served as the principal investigator for the All of Us Data and Research Center.